Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study Meeting Abstract
| Authors: | De Wit, R.; Vaughn, D. J.; Fradet, Y.; Fong, L.; Vogelzang, N. J.; Duran, M. A. C.; Necchi, A.; Petrylak, D. P.; Gerritsen, W. R.; Gurney, H. P.; Quinn, D. I.; Culine, S.; Sternberg, C. N.; Bajorin, D. F.; Choueiri, T. K.; Xu, J.; Imai, K.; Moreno, B. H.; Bellmunt, J.; Lee, J. L. |
| Abstract Title: | Impact of prior chemotherapy (Chemo) on pembrolizumab (Pembro) response in urothelial cancer (UC): Exploratory analysis of the phase III KEYNOTE-045 study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1336 |
| End Page: | S1337 |
| Language: | English |
| ACCESSION: | WOS:000866211602297 |
| DOI: | 10.1016/j.annonc.2022.07.1825 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1747P -- Source: Wos |
